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Abstract
A challenge experiment was performed to investigate whether administration of Mycobacterium avium subsp.
paratuberculosis (MAP) via the respiratory route leads to MAP infection in calves. Eighteen calves from test negative
dams were randomly allocated to four groups. Six calves were challenged with MAP nasally and six calves were
challenged by transtracheal injection; three orally challenged calves served as positive controls, and three non
challenged calves as negative controls. The challenge was performed as a nine-fold trickle dose, 10
7 CFU in total.
Blood and faecal samples were collected frequently. Calves were euthanized three months post-challenge and
extensively sampled. Blood samples were tested for the presence of antibodies and interferon gamma producing
cells by ELISA. Faecal and tissue samples were cultured in a liquid culture system and the presence of MAP was
confirmed by IS900 realtime PCR. Fourteen out of fifteen calves had no MAP antibody response. The negative
controls remained negative; all positive controls became infected. Two nasally challenged calves showed a Purified
Protein Derivative Avian (PPDA) specific interferon gamma response. In all nasally challenged calves, MAP positive
intestinal samples were detected. In three calves of the nasal group MAP positive retropharyngeal lymph nodes or
tonsils were detected. In all calves of the transtracheal group MAP positive intestinal tissues were detected as well
and three had a MAP positive tracheobronchial lymph node. These findings indicate that inhalation of MAP
aerosols can result in infection. These experimental results may be relevant for transmission under field conditions
since viable MAP has been detected in dust on commercial dairy farms.
Introduction
Paratuberculosis or Johne’s disease (JD) is a chronic enteri-
tis of ruminants caused by Mycobacterium avium subspe-
cies paratuberculosis (MAP). The well-accepted
transmission route of MAP is the oral uptake of bacteria
by susceptible calves via colostrum, milk, water or food
contaminated with faeces from MAP-shedding cattle [1].
In addition, intrauterine transmission has been described
[2]. Due to limited effectiveness of control programs and
the fact that eradication could not be achieved, other non-
identified transmission routes have been suggested [3-5].
Recently, MAP has been identified in settled dust sam-
ples collected on dairy farms under experimental and
field conditions [6,7]. Currently, JD prevention programs
do not include management practices to reduce dust
production, spread of dust or exposure of susceptible
calves to dust. All existing recommendations to decrease
the risk of new infections of MAP in dairy operations
are directly aimed at reducing the infection rate in
calves by decreasing the contact with faeces of adult
cows [8,9]. MAP containing dust may cause infection in
susceptible calves via ingestion due to normal calf beha-
viour (exploring the environment by licking and suck-
ling). In addition, inhalation of MAP containing dust
may also represent a route of transmission. In sheep,
experimental intratracheal infection has been successful
in the past [10]. However, inhalation of MAP by cattle
has only been hypothesized as a possible route of trans-
mission [4]. * Correspondence: s.w.f.eisenberg@uu.nl
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experiment to investigate whether inhalation of MAP
can establish infection in dairy calves. Particle size of
dust determines how deep particles can penetrate into
the lungs. In humans it has been determined that
inhaled particles of approximately 5 μm will be cleared
by the mucociliary system of the respiratory tract and
subsequently ingested (inhalable dust). Most particles <
5 μm can reach the alveoli and are called respirable dust
[11]. A similar deposition and clearing pattern of aero-
sols was found in the lungs of calves [12]. Therefore,
the influence of particle size on clearing in the respira-
tory tract of calves was assumed to be similar to
humans. Two inoculation routes were tested in this
study, intratracheal inoculation mimicking the uptake of
respirable dust and aerosolized MAP mimicking the
uptake of inhalable dust particles. In early MAP infec-
tion (< 13 weeks) humoral immune responses as well as
macroscopic and histological lesions are unlikely to
occur [13,14]. After experimental MAP inoculation in
calves, specific cellular immune responses could be
detected early by interferon gamma assays and tissue
culture could confirm infection status [15-17]. There-
fore, colonization of tissue determined by culture was
used to confirm successful intestinal infection in this
study.
Materials and methods
Animals
Fourteen newborn Holstein Friesian male calves, one
male twin and one male/female twin (total of 18) were
obtained from nine dairy farms located around Cal-
gary, Alberta, over a period of five weeks. Donor-herds
were identified as low MAP prevalent (< 5%) in a
MAP prevalence study in 2009 by testing individual
faecal, serum and milk samples of cows over 36
months of age. Faecal samples were cultured by para-
JEM automated MAP culturing (para-JEM
®,T R E K
Diagnostic Systems, Cleveland, OH, USA) and serum
and milk samples were analyzed for MAP antibodies
by Pourquier ELISA (IDEXX Laboratories, Inc, West-
brook, Maine, USA). Only calves of first and second
lactation cows were included in the study. Faecal and
serum samples of dams were collected at the day of
parturition to confirm individual animal negative MAP
status by both liquid culture and ELISA. All samples
of dams tested negative. Calves were separated from
their dam directly after birth and a pre-colostral serum
sample was collected and used to check for BVD car-
riers. The calves were transported to the research facil-
ity and fed 6 L of gamma-irradiated colostrum
(Hamilton McMaster Nuclear Reactor, Ontario,
Canada) within 6 h, followed by milk replacer and calf
starter grain without antimicrobial additives.
Calves were housed individually on sawdust bedding
in a biosecurity level 2 barn. The barn was heated and
the temperature was maintained at a minimum of 14°C
for the duration of the trial. The health status was mon-
itored on a daily base by clinical inspection. The proto-
col was approved by the Health Sciences Animal Care
Committee (M09083) at the University of Calgary and
performed according to Canadian Council of Animal
Care regulations.
Inoculum
A virulent cattle type MAP strain isolated from a clini-
cal JD case in Alberta (Cow 69), with an IS900-RFLP
profile identical to the K10 reference strain recom-
mended in the literature, was used [18]. To mimic field
c o n d i t i o n st h ed o s a g ec h o s e nw a sc l o s et oo n eo ft h e
lowest described to be infective when administered
orally [16] which was also plausible for uptake through
respiration. Data about dust concentrations in cattle
housing [19,20] and the tidal volume of calves (8 mL/kg
bodyweight) were used to estimate that a calf approxi-
mately inhales 700 mg of dust in the first 3 months of
life via respiration alone excluding exploratory licking
and suckling behaviour. It was shown that 10
5 CFU of
viable MAP/mg dust can be detected in dust samples on
commercial dairy farms [7]. The challenge dose was 8 ×
10
5 CFU/dose administered on 3 consecutive days for 3
weeks in a row (trickle dose) leading to exposure of
calves to approximately 1 × 10
7 CFU which is one of
the lowest dosages described to cause infection after
oral inoculation [16].
MAP colonies were grown in 7H9/mycobactin/gly-
cerol/OADC broth at 37°C shaking at 100 RPM. The
inoculum was tested for contamination with Gram
staining and subculture to blood agar. The inoculum
was vortexed with 3-4 1 mm glass beads to eliminate
clumps and checked for viability using a fluorescent
Live/Dead
® BacLight™ Bacterial Viability kit (Invitro-
g e n ,B u r l i n g t o n ,O N ,C a n a d a ) .S u b s e q u e n t l y ,M A Pw a s
quantified using the “pelleted wet weight method” as
previously described, where the pelleted wet weight
averaged approximately 1 × 10
7 CFU/mg [18]. Aliquots
of 1.7 mg of MAP/tube were frozen at -80°C to be used
as inoculum for each inoculation series. A separate ali-
quot of MAP was used for each week of inoculation.
Prior to each inoculation, a tube was thawed and
inoculated in 100 mL of 7H9/mycobactin/glycerol/
OADC medium at 37°C shaking at 100 RPM for 5 days.
MAP dose per mL was assessed using an in-house
quantitative realtime PCR with a standard curve based
on the 16 s rRNA gene of Mycobacterium smegmatis
confirming the presence and the quantity of the 16 s
rRNA gene using primers p882 (5’-aggattagataccctggtag-
3’) and p1100 (5’-gctgacgacatccatgc-3’). The inoculum
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10
5 CFU/mL and was stored at 4°C until just prior to
the inoculation for a maximum of three days.
Study design
Calves were assigned randomly to one of the four
groups. Six calves were inoculated by transtracheal
inoculation, six by nasal aspiration of aerosolized
MAP, three were inoculated orally, and three did not
receive a MAP challenge and served as negative con-
trol. Transtracheal inoculation with 5 mL of inoculum
was performed using a technique described in the lit-
erature for the collection of bronchoalveolar fluid in
calves without sedation [21]. Aerosolized inoculums (5
mL) with a variable size were administered using a
nasal spray pump during inspiration of the calf directly
into the nostril [22]. Oral inoculation was performed
to prove pathogenicity of the administered strain at
the dosage used for the other challenge routes by
allowing calves to suckle a syringe containing 5 mL of
MAP suspension. Negative controls were used to sup-
port the negative status of the collected calves and to
detect unexpected MAP transmission during the trial.
In addition, dust samples were collected with an elec-
trostatic dust collector (EDC) to detect environmental
contamination with MAP.
An overview of all samples collected during the trial is
given in Table 1. At week 12 after the first challenge,
euthanasia was performed using intravenous injection of
barbiturate (pentobarbital sodium 540 mg/mL, Euthanyl
Forte
®, DIN 00241326, Bimeda-MTC Animal Health,
Cambridge, Ontario, Canada) and necropsy was per-
formed immediately afterwards.
Necropsies
During necropsies no other ruminants were allowed in
the necropsy room. One calf was opened at a time. At
post-mortem, a total of 18 tissue samples were collected
per calf with separate sterile instruments for each sample.
Three parts of the ileum were sampled with adjacent
lymph nodes (ileocaecal valve, middle and proximal parts
of the ileum) as well as four parts of the jejunum with
adjacent lymph nodes (0.5, 1, 1.5 and 2 m proximal from
the proximal ileum). Additionally, the tonsils, the retro-
pharyngeal lymph nodes and right cranioventral lobe of
the lung with tracheobroncheal lymph nodes were col-
lected. In case of macroscopic lung pathology the abnor-
mal lung tissue was sampled additionally. To minimize
cross contamination, samples were collected in the fol-
lowing order: tonsils, retropharyngeal lymph nodes and
lung tissue were collected first, then parts of interest of
the intestinal tract were identified, marked and adjacent
Table 1 Overview of samples collected during the trial
Type of
sample
Total Frequency Pool Analysis Reason
F0;
before inoculation
3 calves per pool:
1: oral
2: no challenge
3a&b: T-tracheal
4a&b: Nasal
Faecal MAP shedding before
infection
Faeces 13 per calf Week 1 F1-3 pi
Week 2 F4-6 pi
Week 3 F7-9 pi;
Each of 3 days following
weekly inoculation.
3 samples of 2 calves
per pool:
1a&b: oral
2a&b: no challenge
3a, b&c: T-tracheal
4a, b&c: Nasal
Liquid MAP culture with
confirmation IS900 PCR
Passive faecal MAP shedding
after inoculation
Week 6 F10 pi 3 calves per pool:
1: oral
2: no challenge
3a&b: T-tracheal
4a&b: Nasal
Faecal MAP Shedding
Week 9 F11 pi Individually
Week 12 F12 pi Individually Faecal MAP Shedding
Dust 18; at each
stall
Week 11 pi Individually Liquid MAP culture with
confirmation IS900 PCR
Environmental contamination
with MAP
Serum 2 per calf Week 0 pi
Week 12 pi
Individually Commercial JD-ELISA B-cell activation&
seroconversion
Whole
blood
1 per calf Week 12 pi Individually Bovigam
® interferon gamma
essay
T-cell sensitisation
Tissue 18 (19*)
per calf
W 12 pi Individually Liquid MAP culture with
confirmation IS900 PCR
Tissue colonisation with MAP
Overview of the samples collected. Frequencies and time points of collection and tests used for analysis during the 12 week trial are described. Additionally, the
reason for sampling is indicated. F = faecal sample, pi = post inoculation, T-tracheal = transtracheal. *an additional piece of lung was sampled from one calf.
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the intestinal tissue. Equipment and the necropsy room
were cleaned and disinfected between necropsies.
Sample analysis
Serum samples of the calves were analysed for MAP
specific antibodies using Pourquier ELISA following the
manufacturer’s instructions. The results were expressed
as sample to positive ratio (S/P-ratio) using the kit posi-
tive control to correct for inter-plate variation as per the
manufacturers instruction.
Whole blood was analyzed by Bovigam
® (Prionics,
Lavista, USA) to detect T-cell sensitization. Samples
were stimulated within 8 hours after blood collection in
a 24-well tissue culture plate. Commercially available
antigens were used to incubate cells. Purified Protein
Derivative Avian (PPDA; Prionics) and Purified Protein
Derivative Bovis (PPDB; Prionics) included with the
Bovigam
® a s s a yw e r eu s e da ss p e c i f i ca n t i g e n s .P o k e -
weed mitogen (PMT; Sigma Aldrich, Oakville, Ontario)
was used as a positive control and PBS (pH 7.4) as a
negative control. The supernatant was stored at -20°C
until analysis. The results were expressed as the S/N
ratio using the PBS stimulated sample to correct as per
the manufacturer’s instruction.
Faecal samples of calves were analysed as described in
Table 1 and dust samples were tested individually. Dust
samples were decontaminated and prepared as described
previously [7]. All faecal samples were decontaminated
and prepared for culturing in liquid medium (TREK
para-JEM
®) according to the instructions provided by
the manufacturer.
Intestinal samples (4 × 4 cm) were rinsed in PBS to
remove intestinal contents and the mucosa was scraped
off the intestinal wall using slides. The tissue was put into
50 mL tubes prefilled with 20 mL of 1/2 strength Brain
Heart Infusion (BHI) containing 0.9% hexadecylpyridinium
chloride (HPC). The lymph nodes (2 g) and pieces of lung
were cut open and put into stomacher bags with 5 mL of
NaCl. Samples were homogenized with a Stomacher
®
(Stomacher
® 80 Biomaster, Seward Laboratory Systems
Inc., Bohemia, New York, United States) for 1 min at high
speed. Fluid containing debris was poured into a 50 mL
tube containing 20 mL 1/2 strength BHI with 0.9% HPC.
Samples were incubated overnight at 35°C. The next day,
tubes were centrifuged at 1700 g for 20 min, the superna-
tant was discarded, the pellet was resuspended in 1 mL 1/
2 strength BHI containing antibiotics (vancomycin and
naladixic acid 100 μg/mL, amphotericin 50 μg/mL) and
incubated overnight.
After these initial decontamination and preparation
steps faecal, dust and tissue samples were incubated at
35°C for 42 days in para-JEM
® liquid culture medium.
MAP presence was confirmed by IS900 realtime PCR on
culture medium as previously described [7]. Culture
results were considered as a binominal outcome (MAP
detected/not detected).
Data analysis
Interferon gamma results were analyzed by ANOVA ana-
lysis comparing the S/N-ratios of the 4 experimental
groups. The number of positive tissue cultures per calf
was recorded and presented per location. An inoculation
route was considered to be successful if at least one calf
per group had at least one culture positive intestinal tissue.
Results
Clinical findings
During the study no severe clinical abnormalities were
detected. Several calves had a dry cough throughout the
experimental period. It occurred in all groups before
and also several weeks after inoculation. One calf in the
nasal group was diagnosed with and treated for pneu-
m o n i aw i t h i nt h ef i r s tw e e ko fl i f eb e f o r ei n o c u l a t i o n .
Slight diarrhoea was detected in 3 calves; in one it
occurred before inoculation, and in the other 2 in week
6 post inoculation (pi).
Calves showed no reaction after nasal inoculation.
Some calves inoculated trans-tracheally reacted with a
slight cough to the injection of fluid into the trachea.
Twice traces of blood were detected in the nostrils after
transtracheal injection.
Immune parameters
Serum samples of calves at day 3 of life and D82 after
inoculation were negative for MAP specific antibodies in
the ELISA with the exception of one calf from the oral
inoculation group.
In all calves, interferon gamma production of cells sti-
mulated with PBS and PPDB were negligible. Stimulation
with PMT showed a clear interferon gamma response in
all animals. Two calves of the nasal inoculation group
had a more prominent interferon gamma response to
PMT. After stimulation with PPDA the interferon
gamma production was comparably low in the negative
control, the positive control and the transtracheal inocu-
lated group. In the nasal inoculation group, the two
calves with the prominent interferon gamma response to
PMT also showed a high response to PPDA. A significant
(p = 0.002) difference was found between the nasal
inoculated and the positive control group.
Necropsy
No macroscopic intestinal lesions were observed in any
of the calves at necropsy. The calf in the nasal group
treated for pneumonia showed a few pleural adhesions.
No MAP could be detected in an additional piece of
lung tissue collected underneath the adhesions.
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All faecal samples of the calves collected throughout the
trial were culture negative. All 18 dust samples collected
8 weeks after the last inoculation were also culture
negative. Culture results of tissue samples are summar-
ized in Table 2. No MAP could be detected in the tissue
of the negative control group. Intestinal MAP infection
occurred in all inoculated calves.
Nasal inoculated calves showed up to 6 MAP positive
intestinal tissue samples, whereas transtracheal inoculated
calves had a maximum of 4 positive intestinal tissue sam-
ples. Nasal inoculation led to the presence of MAP in the
tonsils of 1 calf and in the retropharyngeal lymph node in
2 other calves. Transtracheal application of MAP resulted
in a positive tracheobronchial lymph node in 3 calves.
Discussion
This study supports the hypothesis that MAP might be
transmitted via bioaerosols since a low trickle dose
administered via nasal and transtracheal routes could
establish MAP infection in all inoculated calves. Both
respiratory routes caused infection of intestinal tissue
and intestinal lymph nodes.
In sheep intratracheal MAP exposure has been pre-
viously described as a potential route of infection [10].
T h en u m b e ro fc a l v e su s e di nt h i ss t u d yw a st o os m a l l
to statistically compare results for tissue locations
between groups, but the goal was a proof of principle.
The presence of MAP in cultured intestinal tissue and
lymph node samples of all challenged calves (Table 2)
supports that MAP uptake via the respiratory tract can
induce MAP infection in susceptible calves. Recent
detection of MAP in bioaerosols on commercial dairy
farms indicates that this route has to be considered as a
possible route of transmission [6].
Intermittent faecal shedding due to infection has been
described in experimental trials as early as 146 days post
challenge [13]. Since calves in this study were inoculated
with a lower dose per inoculation day compared to lit-
erature and were euthanized at 12 weeks pi, no presence
of MAP in any faecal sample was expected. In early
MAP infection, no macroscopic lesions occur and histo-
logical lesions containing acid-fast bacteria can be
detected sporadically if at all [13,14]. Therefore in this
study, confirmation of MAP infection in tissue samples
was performed by MAP culture.
Table 2 Summary of tissue culture results
Group Total no. Positive out
of 18
CaeV CaeV
ln
Il
1
Il 1
ln
Il
2
Il 2
ln
Je
1
Je 1
ln
Je
2
Je 2
ln
Je
3
Je 3
ln
Je
4
Je 4
ln
Lu
1
TB Re To
No
chal.
0
No
chal.
0
No
chal.
0
Oral 1 +
Oral 2 ++
Oral 1 +
Nasal 7 +++++ + +
Nasal 1 +
Nasal 1 +
Nasal 3 ++ +
Nasal 1 +
Nasal 4 ++ + +
T-
Trach
4 +++ +
T-
Trach
2 ++
T-
Trach
2 ++
T-
Trach
4 ++ + +
T-
Trach
3 ++ +
T-
Trach
2 ++
MAP presence in tissue was confirmed by IS900 realtime PCR on liquid culture medium. No chal: no challenge, T-trach: transtracheal; CaeV = caecoilio valves, ln =
lymph node, Il = ileum, Je = jejunum, Lu = lung, TB = tracheobroncheal lymph node, Re = retropharyngeal lymph node, To = tonsils.
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commercially available ELISA tests has occurred earlier
in experimental infection studies than in naturally
infected cattle, but not before 406 days after inoculation
[13,23,24]. The absence of MAP specific antibodies
shortly after birth showed the absence of maternal anti-
bodies in colostrum administered to the calves. Not
detecting antibodies in 14 out of 15 challenged calves in
week 12 after inoculation was in agreement with pub-
lished studies indicating seroconversion so early after
challenge to be a rare event. The interferon gamma
assay detects cellular immune responses and was
deemed useful for early paratuberculosis detection in
cattle [15,25]. In experimental studies in calves, inter-
feron gamma production has been detected as early as
day 7 after intra-peritoneal inoculation [15]. However,
after oral inoculation (4 times of 1-2 × 10
10 CFU/dose)
interferon gamma production did not increase before
day 90 pi and was considered a robust measure only
after 6 months of age [15]. In the present study, calves
were inoculated with a considerably lower dose and
were euthanised before 90 days post inoculation (dpi)
explaining the low specific interferon gamma response
in the oral inoculation group. Surprisingly, two calves
inoculated through the nasal route showed a clear inter-
feron gamma response after specific antigen stimulation
as early as 12 weeks pi. These findings and negligible
responses to stimulation with PBS and PPDB indicate a
specific sensitization of peripheral blood mononuclear
cells to MAP after nasal inoculation.
Faecal-oral transmission of MAP is believed to be the
most common route of transmission under field condi-
tions [1,26]. In addition, this route of inoculation has
been frequently confirmed to be effective in experiments
[18]. Therefore, the positive control group was inocu-
lated orally with the same inoculation scheme and dose
as the experimental groups. All 3 positive control calves
became infected (Table 2), although the total dose (1 ×
10
7 CFU/dose) and the dose given per inoculation day
(8 × 10
5 CFU/dose) was low [18]. A dose of 1.5 × 10
6
CFU/dose for 2 consecutive days reliably induced
detectable infection, whereas a dose of 2 × 10
5 CFU/
dose did not [16]. In this study the daily oral dosage
was lower than 10
6 CFU/dose and probably only led to
an infection because it was administered several times
as a trickle dose adding up to a total dose around 10
7
CFU.
In humans, aerosol routing after aspiration has been
described to be dependent on droplet size [11,27]. Simi-
lar estimates for particle penetration into the respiratory
tract have been performed in calves [12]. To mimic
aerosol infection by droplets in the upper respiratory
tract a device was used to administer the inoculum to
the nasal group which was designed for intranasal
application in humans. It produced aerosols with a vari-
able size which were mainly trapped in the mucociliary
system of the nose [22]. Thus, most MAP would have
reached only the nasal cavity passing the nasal asso-
ciated lymphoid tissue (NALT) before being cleared by
the mucociliary system and ingested [28]. NALT con-
tains M-cells which have been shown to facilitate MAP
uptake in Peyers patches of gut associated lymphoid tis-
sue (GALT) after oral uptake [29,30]. After nasal inocu-
lation, MAP would come into direct contact with NALT
and thus with M cells; it would also pass by the palatine
tonsils before being swallowed and diluted by saliva.
Therefore, when presented to M cells in NALT, uptake
of MAP might occur via a similar mechanism to that
which occurs during oral infection; respiratory uptake
m a yb ee v e nm o r ee f f i c i e n ts i n c ei nt h i sc a s eM A Pi s
not diluted in intestinal contents before reaching the
target tissue. In addition, when inhaled, surplus MAP
will be swallowed and M-cells in the Peyers patches
subsequently will be exposed. Confirmation of MAP in
retropharyngeal lymph nodes and in tonsils of calves of
the nasal inoculation group supports that the nose can
act as a portal of entry for MAP.
Transtracheal application of MAP was performed,
mimicking the scenario of MAP attached to respirable
dust. Particles and bacteria entering alveoli will be taken
up by pulmonary-alveolar macrophages and removed by
the mucociliary system, passing the tonsils before being
swallowed; alternatively they could pass the mucosal
epithelial barrier [12,31,32]. M-cells in bronchus-asso-
ciated lymphoid tissue (BALT) have been described as a
portal of entry for Mycobacterium bovis in mice [33].
BALT is not present in the neonatal bovine lung, but
can be detected after 4 months of age [34] indicating
that BALT could play a role in MAP uptake in older
young stock but not in the present study. In this study,
MAP was possibly cleared by pulmonary-alveolar
macrophages and partially passed the mucosal epithelial
barrier indicated by confirmed positive tracheobroncheal
lymph nodes in 3 calves of the transtracheal group.
These findings support that the lung can act as a portal
of entry for MAP.
After oral inoculation and uptake by M cells of the
Peyers patches, macrophages are the target cells since
MAP is capable of interfering with bactericidal mechan-
isms of these cells [35]. Within macrophages, MAP
migrates to the regional lymph nodes [14] and in later
stages of disease the whole body is colonized [36-38].
Older oral infection studies detected MAP in lymphoid
tissue of the pharyngeal area shortly after inoculation,
followed later on by the intestinal tract and other organs
indicating dissemination via the reticuloendothelial sys-
tem to reach the intestinal tissue [39,40]. This theory
was supported by the finding that instillation of MAP in
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[13]. In addition, intraperitoneal inoculation proved to
be effective for inducing infection [41]. In this study
MAP lymph nodes close to the inoculation site were
positive, as well as intestinal tissue and lymph nodes,
indicating that migration occurred as well. Intestinal
colonization when inoculated orally, intraperitoneally
and directly into the tonsils and now also nasally and
transtracheally supports that migration of MAP has to
occur once it has passed the epithelial barrier [16,41,42].
In conclusion, intestinal MAP infection can be
induced via the respiratory route when administered
into the nose or the trachea of young calves. If MAP
uptake after inoculation occurred through the nose and
lung tissue directly as hypothesized or due to ingestion
after mucociliary clearance maintains unclear. Neverthe-
less intestinal infection occurred indicating that bioaero-
sols can be a route of transmission. Since MAP has
been detected in bioaerosols on dairy farms, the trans-
mission of MAP by bioaerosols will need to be consid-
ered in MAP control programs in addition to the faecal-
oral route.
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